CVR Partners
Valuation each multiple against its own 5-year range
Vs. peers Agricultural Inputs
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| CVR Partners (UAN) | 1.01B | 9.45 | 3.70 | 15.22% |
| Nutrien (NTR) | 30.27B | 13.94 | 1.18 | 3.44% |
| CF Industries Holdings (CF) | 16.90B | 8.15 | 2.95 | 1.82% |
| The Mosaic (MOS) | 5.93B | -5.29 | 0.53 | 4.72% |
| ICL Group (ICL) | 5.27B | 16.32 | 0.85 | 5.07% |
| Corteva (CTVA) | 5.27B | 6.86 | 0.21 | 9.13% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 21.3% below Morningstar's fair value estimate.
Fair value
CVR Partners LP receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 2% discount to our quantitative fair value estimate of $115.32 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The firm's profitability bolsters our quantitative valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 10.0%, which lies in the top 30% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.
The company's favorable dividend structure is an additional encouraging factor. Dividends represent a stable form of future cash flows returned to shareholders, reducing the perceived risk of a business. The firm's forward dividend yield of 13.2%, for example, ranks in the top 10% globally. Expected dividend payments over the coming year relative to the current share price are favorable, which further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
CVR Partners discussion 0 comments